Journal
EXPERT OPINION ON THERAPEUTIC PATENTS
Volume 18, Issue 10, Pages 1127-1139Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1517/13543776.18.10.1127
Keywords
dual PDE7/PDE4 inhibitors; inflammatory diseases; neurological diseases; PDE7 inhibitors
Categories
Ask authors/readers for more resources
Background: Phosphodiesterase 7 (PDE7) is a high affinity CAMP-specific PDE whose functional role in T cells has been the subject of some controversy. Recent findings on tissue distribution, however, support the hypothesis that PDE7 could be a good target for the treatment of airway diseases, T-cell related diseases or even CNS disorders. Objective/method: This review discloses recent discoveries of selective PDE7 and PDE4/PDE7 dual inhibitors with special emphasis on their potential for neurological and inflammatory diseases. Conclusion: PDE7 inhibitors constitute a new approach to be explored for the treatment of neurodegenerative disorders.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available